SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001521536-13-000886
Filing Date
2013-10-31
Accepted
2013-10-31 16:26:53
Documents
4
Period of Report
2013-10-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 q1101301_8k-biozone.htm 8-K 26267
2 CERTIFICATE OF DESIGNATION q1101301_ex3-1.htm EX-3.1 152980
3 FORM OF SECURITIES PURCHASE AGREEMENT q1101301_ex10-1.htm EX-10.1 232947
4 FORM OF WARRANT q1101301_ex10-2.htm EX-10.2 104613
  Complete submission text file 0001521536-13-000886.txt   518194
Mailing Address 550 SYLVAN AVENUE, SUITE 101 ENGLEWOOD CLIFFS NJ 07632
Business Address 550 SYLVAN AVENUE, SUITE 101 ENGLEWOOD CLIFFS NJ 07632 201-608-5101
BIOZONE PHARMACEUTICALS, INC. (Filer) CIK: 0001412486 (see all company filings)

IRS No.: 205978559 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 333-146182 | Film No.: 131183054
SIC: 2834 Pharmaceutical Preparations